The goal of this research is to determine whether benfotiamine, a synthetic version of thiamine or vitamin B1, is a treatment for mild cognitive impairment or early Alzheimer’s Disease.

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

A woman from Eastbourne has been awarded a British Empire Medal (BEM) in the King’s Birthday Honours list in recognition of ...